Biolegend, 100311, APC anti-mouse CD3ε Antibody, 25μg

CD3ε is a 20 kD transmembrane protein, also known as CD3 or T3. It is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3ε forms a TCR complex by associating with the CD3δ, γ and ζ chains, as well as the TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex.
25μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Armenian Hamster
Immunogen: H-2Kb-specific mouse cytotoxic T lymphocyte clone BM10-37
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration: 0.2 mg/ml
Storage & Handling: The CD3ε antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Red Laser (633 nm)
Application Notes: Clone 145-2C11 is useful for in vitro blocking of target-specific CTL-mediated cell lysis1, as well as T cell activation assays, inducing proliferation and cytokine production1,2,7,12,16. It also induces apoptosis in immature thymocytes32, and in vivo T cell depletion8-10. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1, immunohistochemical staining14,15 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, Western blotting4, complement-mediated cytotoxicity6, in vitro and in vivo stimulation of T cells1,2,7,12,16, immunofluorescent staining5, and in vivo T cell depletion8-10. The 145-2C11 antibody has been reported to block the binding of 17A2 antibody to CD3 epsilon-specific T cells11. Clone 145-2C11 is not recommended for formalin-fixed paraffin embedded sections. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 100314). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100340) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).
Application References(PubMed link indicates BioLegend citation): Leo O, et al. 1987. P. Natl. Acad. Sci. USA 84:1374. (IP, Activ, Block) Kruisbeek AM, et al. 1991. In Current Protocols in Immunology. 3.12.1. (Activ) Duke RC, et al. 1995. Current Protocols in Immunology. 3.17.1. Salvadori S, et al. 1994. J. Immunol. 153:5176. (WB) Payer E, et al. 1991. J. Immunol. 146:2536. (IF) Jacobs H, et al. 1994. Eur. J. Immunol. 24:934. (CMCD) Vossen ACTM, et al. 1995. Eur. J. Immunol. 25:1492. (Activ) Henrickson M, et al. 1995. Transplantation 60:828. (Deplete) Kinnaert P, et al. 1996. Transpl. Int. 9:386. (Deplete) Han WR, et al. 1999. Transpl. Immunol. 7:207. (Deplete) Miescher GC, et al. 1989. Immunol. Lett. 23:113. (Block) Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Activ) Ko SY, et al. 2005. J. Immunol. 175:3309. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC-F) Tilley SL, et al. 2007. J. Immunol. 178:3208. (IHC-F) Wang W, et al. 2007. J. Immunol. 178:4885. (Activ) Xiao S, et al. 2007. J. Exp. Med. 204:1691. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed. Curtsinger JM, et al.2005. J. Immunol. 175:4392. PubMed Guo Y, et al. 2008. Blood 112:480. PubMed Kenna TJ, et al. 2008. Blood 111:2091. Perchonock CE, et al. 2007. J. Immunol. 179:1768. PubMed Perchonock GE, et al. 2006. Mol. Cell. Biol. 26:6005. PubMed Kanaya T, et al. 2008. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G273. PubMed de Koning BA, et al. 2006. Int. Immunol. 18:941. PubMed Schulteis RD, et al. 2008. Blood 295:G273. PubMed Qi Q, et al. 2009. Blood 114:564. PubMed Helmersson S, et al. 2013. Am J Pathol. 9440:123. Pubmed Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed Yan J, et al. 2014. Vaccine. 32:2833. PubMed Guiterrez DA, et al. 2014. Diaebetes. 63:3827. PubMed Shi YF, et al. 1991. J Immunol. 146:3340. (Apop)
Product Citations: Barrett N, et al. 2016. Cell Rep. 16: 1039-1054. PubMed Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed Zhu Z, et al. 2022. Clin Cancer Res. 28:4820. PubMed Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed Wang Q, et al. 2020. Radiat Environ Biophys. 59:89. PubMed Nelson J, et al. 2020. Sci Adv. 6:eaaz6893. PubMed Li H, et al. 2022. Cancer Cell. 40:36. PubMed Wang B, et al. 2022. EMBO J. 41:e108946. PubMed Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed Cha JH, et al. 2022. J Biol Chem. 298:101817. PubMed Khayrullina G, et al. 2022. Glia. 70:1337. PubMed Gargaro M, et al. 2022. Immunity. 55:1032. PubMed Chen C, et al. 2022. Sci Adv. 8:eabo4363. PubMed Kumpunya S, et al. 2023. Front Immunol. 13:1010764. PubMed Sieow JL, et al. 2023. Int J Mol Sci. 24: . PubMed Agrafiotis A, et al. 2023. Acta Neuropathol. 145:335. PubMed Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed Drijvers JM, et al. 2021. Cancer Immunol Res. 9:184. PubMed Sohn J, et al. 2022. Blood Adv. 6:2557. PubMed Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed Pennock N, et al. 2014. Proc Natl Acad Sci U S A. 111:16472. PubMed Ajina R, et al. 2019. Oncoimmunology. 8:e1577127. PubMed Yamaguchi S, et al. 2021. Eur J Immunol. 51:2306. PubMed Yang Z, et al. 2022. J Immunother Cancer. 10:. PubMed Fujimori S, et al. 2022. Elife. 11:. PubMed Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed Symeonidou V, et al. 2021. Cell Rep. 37:109900. PubMed Okamoto M, et al. 2014. J Immunol. 192:2770. PubMed Nakamura M, et al. 2015. J Immunol. 194:243. PubMed Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed Roufaiel M, et al. 2016. Nat Immunol. 10.1038/ni.3564. PubMed Ku M, et al. 2016. Mol Cancer Ther. 15: 1975 - 1987. PubMed Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed Yang X, et al. 2020. Blood Sci. 2:89. PubMed Volpedo G, et al. 2022. NPJ Vaccines. 7:32. PubMed Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed Jung BG, et al. 2022. PLoS Pathog. 18:e1010454. PubMed Haugh KA, et al. 2021. eLife. 0.416666666666667. PubMed Sato K, et al. 2015. PLoS One. 10: 0138291. PubMed Lercher A, et al. 2019. Immunity. 51:1074. PubMed Gao JL, et al. 2019. JCI Insight. 4:e132140. PubMed Gorczynski RM, et al. 2017. Immunology. 150:418. PubMed Wang J, et al. 2018. Front Immunol. 9:371. PubMed Zhou H, et al. 2022. EMBO Rep. 23:e53475. PubMed Wan W, et al. 2015. Cardiovasc Res. 106:478. PubMed Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed Dane EL, et al. 2022. Nat Mater. 21:710. PubMed Leiva M, et al. 2016. Nat Commun. 7:10222. PubMed Holvoet B, et al. 2015. Stem Cell Reports. 5: 1183-1195. PubMed Burrack K, et al. 2015. PLoS Pathog. 11: e1005191. PubMed Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed Codina A, et al. 2019. Cell Syst. 8:136. PubMed Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed Dong S, et al. 2021. Nature. 591:117. PubMed Ghandhi SA, et al. 2022. Sci Rep. 12:14124. PubMed Mansell E, et al. 2020. Cell Stem Cell. . PubMed Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed Siggs O, et al. 2015. Proc Natl Acad Sci U S A. 112: E5706 - E5714. PubMed Burrack K, et al. 2015. J Immunol. 194:678. PubMed Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed Hum NR, et al. 2022. Front Oncol. 12:928474. PubMed , et al. 2021. Eur J Immunol. 51:2708. PubMed Luck H, et al. 2015. Cell Metab. 21 527 . PubMed Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed Zhang H, et al. 2019. Mol Cell. 76:110. PubMed Oksenych V, et al. 2021. Biomolecules. 12:. PubMed Mittal A, et al. 2021. Sci Rep. 11:10731. PubMed Gu X, et al. 2022. Vaccines (Basel). 10:. PubMed Liu B, et al. 2022. Mol Med Rep. 26:. PubMed Uto T, et al. 2016. Nat Commun. 7: 11273. PubMed Rovira-Clavé X, et al. 2016. J Leukoc Biol. 99: 143 - 152. PubMed XS R, et al. 2015. Diabetes. 64 90. PubMed Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed Ghandhi SA, et al. 2019. Sci Rep. 9:19434. PubMed Xia P et al. 2018. Immunity. 48(4):688-701 . PubMed Liu S, et al. 2018. Front Immunol. 29:208. PubMed Sun Y, et al. 2022. Mol Ther Oncolytics. 25:160. PubMed Huang J, et al. 2014. J Immunol. 192:1972. PubMed Gubin MM, et al. 2018. Cell. 175:1014. PubMed Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed Liu Y, et al. 2022. Am J Transl Res. 14:6856. PubMed Nahrendorf W, et al. 2021. eLife. 10:00. PubMed Gong N, et al. 2020. Nat Nanotechnol. 1.35625. PubMed Metidji A et al. 2018. Immunity. 49(2):353-362 . PubMed Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed Zhang Q, et al. 2022. JCI Insight. 7:. PubMed Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed Shibuya M, et al. 2021. iScience. 24:103131. PubMed Liang Q, et al. 2020. Front Microbiol. 11:571847. PubMed Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed Onai N, et al. 2020. Int J Mol Sci. :22. PubMed Celik H, et al. 2018. Cancer Cell. 34:741. PubMed Kang YH, et al. 2019. Nat Commun. 10:912. PubMed Castañeda–Zegarra S, et al. 2019. Biomolecules. 0.929166667. PubMed Casanova-Acebes M, et al. 2018. J Exp Med. 215:2778. PubMed Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed Jing Y, et al. 2021. Front Immunol. 12:651860. PubMed Bergquist M, et al. 2014. J Infect. 69:113. PubMed McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed Ulaganathan VK, et al. 2020. Sci Rep. 10:8453. PubMed Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed Bajaña S, et al. 2022. iScience. 25:103732. PubMed Koide S, et al. 2022. iScience. 25:103603. PubMed Zhu E, et al. 2014. J Immunol. 192:5599. PubMed Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed Rousso-Noori L, et al. 2021. Nat Commun. 12:3615. PubMed Zhou S, et al. 2021. Adv Funct Mater. 31:. PubMed Sato Y, et al. 2022. Front Mol Biosci. 9:1040237. PubMed Bonavita E, et al. 2020. Immunity. 1215:53. PubMed Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed Arensman MD, et al. 2020. Oncoimmunology. 9:1800162. PubMed Parks CA, et al. 2019. Proc Natl Acad Sci U S A. 116:3136. PubMed Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed Stephens HM, et al. 2022. Methods Mol Biol. 2478:727. PubMed Sun Y, et al. 2022. iScience. 25:104846. PubMed Xu G, et al. 2015. Free Radic Biol Med. 87: 15-25. PubMed Cruz F, et al. 2016. Stem Cells Trans Med. 5: 488-499. PubMed Huang X, et al. 2021. Immunity. . PubMed Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed Harvey RE et al. 2017. Endocrinology. 158(7):2179-2189 . PubMed Campisi L, et al. 2016. Nat Immunol. 10.1038/ni.3512. PubMed Yu YR, et al. 2020. STAR Protocols. 11(3):e0150606. PubMed Omenetti S, et al. 2019. Immunity. 51:77. PubMed Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
RRID: AB_312676 (BioLegend Cat. No. 100311) AB_312677 (BioLegend Cat. No. 100312)
Structure: Ig superfamily, forms CD3/TCR complex with CD3δ, γ and ζ subunits and TCR (α/β and γ/δ), 20 kD
Distribution: Thymocytes (differentiation dependent), mature T cells, NK-T cells
Function: TCR signal transduction, T cell activation, antigen recognition
Ligand/Receptor: Peptide antigen/MHC-complex
Cell Type: NKT cells, T cells, Thymocytes, Tregs
Biology Area: Immunology
Molecular Family: CD Molecules, TCRs
Antigen References: 1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press. 2. Davis MM. 1990. Annu. Rev. Biochem. 59:475. 3. Weiss A, et al. 1994. Cell 76:263.
Gene ID: 12501
UniProt: View information about CD3epsilon on UniProt.org
Clone: 145-2C11
Regulatory Status: RUO
Other Names: CD3ε, T3, CD3
Isotype: Armenian Hamster IgG